InvestorsHub Logo
Followers 47
Posts 5308
Boards Moderated 0
Alias Born 01/27/2012

Re: inbred_dumass post# 221126

Wednesday, 11/27/2019 11:07:14 AM

Wednesday, November 27, 2019 11:07:14 AM

Post# of 469768
Great question. We dont know but the latest presentation shows the 32 people in a 208 week Ph2a study supported by clinical data at 148 weeks. My glass half full guess is why would the company publish current patient results without being able to support their condition with meaning clinical data. They are still analyzing through AI (kem analysis) the trial results. This can have advantages and disadvantages but judging by what and how the market has treated the entire path Anavex has taken...I would probably be inclined to wait as well. RWE is gaining traction in the scientific world but not in the market world, yet. If and when it does, I speculate, we investors will be the last to find out.

Tred
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News